The Acceptability and Feasibility of an HIV Preexposure Prophylaxis (PrEP) Trial With Young Men Who Have Sex With Men
- 1 April 2013
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 62 (4) , 447-456
Abstract
Background: This study examined the feasibility of a combination prevention intervention for young men who have sex with men (YMSM), an anticipated target population for HIV preexposure prophylaxis (PrEP). Methods: Project PrEPare, a pilot study using a randomized 3-arm design, compared an efficacious behavioral HIV prevention intervention (Many Men, Many Voices—3 MV) alone, 3 MV combined with PrEP (tenofovir/emtricitabine), and 3 MV combined with placebo. Eligible participants were 18- to 22-year-old HIV-uninfected men who reported unprotected anal intercourse in the past year. Participants were screened for preliminary eligibility at youth venues and community organizations and were also referred through social networks. Laboratory screening determined final eligibility. Behavioral and biomedical data were collected at baseline and every 4 weeks thereafter for 24 weeks. Results: Sixty-eight youth (mean age = 19.97 years; 53% African American, 40% Latino) were enrolled; 58 were randomized. Self-reported medication adherence averaged 62% (range, 43%–83%), whereas rates of detectable tenofovir in plasma of participants in the emtricitabine/tenofovir disoproxil fumarate arm ranged from 63.2% (week 4) to 20% (week 24). There were 5 ≥ grade 2 adverse events possibly/probably related to the study medication. Sexual risk behavior declined from baseline to week 24 in all study arms. Conclusions: The feasibility of enrolling at-risk youth, particularly young men who have sex with men of color, into Project PrEPare has been demonstrated. The acceptability of the group intervention along with counseling and testing was high. Self-reported medication adherence and corresponding plasma drug concentrations were low indicating the need for enhanced adherence counseling. Exploration of PrEP use among youth in nonrandomized open label trials is warranted.Keywords
This publication has 16 references indexed in Scilit:
- Considerations regarding antiretroviral chemoprophylaxis in MSMCurrent Opinion in HIV and AIDS, 2012
- Studying the Use of Oral Contraception: A Review of Measurement ApproachesJournal of Women's Health, 2010
- Preexposure Prophylaxis and Predicted Condom Use Among High-Risk Men Who Have Sex With MenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Early Patterns of Adherence in Adolescents Initiating Highly Active Antiretrovial Therapy Predict Long-Term Adherence, Virologic, and Immunologic ControlAIDS Patient Care and STDs, 2009
- Efficacy of an HIV/STI Prevention Intervention for Black Men Who Have Sex with Men: Findings from the Many Men, Many Voices (3MV) ProjectAIDS and Behavior, 2009
- Patient-Related Risks for Nonadherence to Antiretroviral Therapy among HIV-Infected Youth in the United States: A Study of Prevalence and InteractionsAIDS Patient Care and STDs, 2009
- Practical and Conceptual Challenges in Measuring Antiretroviral AdherenceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Adherence to treatment in children and adolescent patients with cystic fibrosisJournal of Adolescent Health, 2006
- Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemiaArchives of Disease in Childhood, 2004
- Adherence to HIV combination therapySocial Science & Medicine, 2000